Could a common gout pill save limbs? new trial aims to find out

NCT ID NCT07536373

First seen Apr 19, 2026 · Last updated May 09, 2026 · Updated 3 times

Summary

This study tests whether a low-dose anti-inflammatory drug called colchicine can help people with severe leg artery disease avoid amputation or death. About 200 adults who recently had a procedure to restore blood flow to their leg will take either colchicine or a placebo daily for one year. The goal is to see if colchicine improves survival without major leg amputation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIMB THREATENING ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chi Mei Medical Center

    Tainan, 710, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Linkou Chang Gung Memorial Hospital

    Taoyuan, 333, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Taiwan University Hospital

    Taipei, 100, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shin Kong Wu Ho-Su Memorial Hospital

    Taipei, Taipei, 111, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taipei Veterans General Hospital

    Taipei, 112, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.